Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells.
Modifications of the cytoskeleton and protein synthesis were investigated in LLC-MK2 cells during infection by FPV/Ulster 73, an avian strain of influenza A virus. During infection, the cytoskeleton and the prosome networks undergo a dramatic reorganization, which seems to be at least temporally differentiated for each cytoskeletal system, i.e. microfilaments (MFs), microtubules (MTs), intermediate filaments (IFs). In order to evaluate the role of the three different cytoskeletal networks during FPV/Ulster infection, studies were carried out on cellular and virus-specific protein synthesis and viral production, using drugs which selectively affect individual cytoskeletal systems. Our data show that the perturbation of the IF system, but not that of the MFs or MTs, seems to have a strong inhibitory effect on virus production and cellular and viral protein synthesis. Furthermore, the dynamics of IFs and prosomes were investigated during viral infection and, at no time, dissociation of the prosome and IF networks was observed. Taken together, these results strongly support the idea that the interactions between the protein synthesis machinery, the cytoskeleton, and the prosomes are all affected by viral infection in a partially coordinated manner.
Arcangeletti
M C
MC
Istituto di Microbiologia, Università degli Studi di Parma, Italy.
Pinardi
F
F
Missorini
S
S
De Conto
F
F
Conti
G
G
Portincasa
P
P
Scherrer
K
K
Chezzi
C
C
D000178:Acrylamides / Q000494:pharmacology; D008841:Actin Cytoskeleton / Q000187:drug effects / Q000378:metabolism / Q000821:virology; D000818:Animals; D002460:Cell Line / Q000821:virology; D015638:Cytochalasin D / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009980:Influenza A virus; D007382:Intermediate Filaments / Q000187:drug effects / Q000378:metabolism / Q000821:virology; D007633:Keratins / Q000378:metabolism; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism / Q000821:virology; D015739:Nocodazole / Q000494:pharmacology; D009976:Orthomyxoviridae Infections / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D014176:Protein Biosynthesis; D011506:Proteins / Q000187:drug effects; D012261:Ribonucleoproteins / Q000502:physiology*; D014746:Vimentin / Q000378:metabolism
D000178:Acrylamides; D011506:Proteins; D012261:Ribonucleoproteins; D014746:Vimentin; D015638:Cytochalasin D; D007633:Keratins; D015739:Nocodazole